Psychology Wiki

Assessment | Biopsychology | Comparative | Cognitive | Developmental | Language | Individual differences | Personality | Philosophy | Social |
Methods | Statistics | Clinical | Educational | Industrial | Professional items | World psychology |

Clinical: Approaches · Group therapy · Techniques · Types of problem · Areas of specialism · Taxonomies · Therapeutic issues · Modes of delivery · Model translation project · Personal experiences ·


At risk mental state is the clinical presentation of those considered at risk of developing psychosis or schizophrenia.[1] Such states were formerly considered treated as prodromes, emerging symptoms of psychosis, but this view is no longer prevalent as as a prodromal period can not be confirmed unless the emergence of the condition has occurred.

The original specialist service for those with subclinical symptoms of psychosis was The Pace Clinic[2] in Melbourne, Australia.[3] Other clinics have since developed around the world.[4][5][6][7]

There has been some considerable development of how the concept can be applied clinically.[8][9][10][11]

Assessed during the structured interview developed by PACE

.[12]

See also[]

References[]

  1. Yung AR, McGorry PD, McFarlane CA, Jackson HJ, Patton GC, Rakkar A (1996). Monitoring and care of young people at incipient risk of psychosis. Schizophr Bull 22 (2): 283–303.
  2. http://www.orygen.org.au/contentPage.asp?pageCode=ATRISK#paceclin
  3. Yung AR, McGorry PD, McFarlane CA, Jackson HJ, Patton GC, Rakkar A (1996). Monitoring and care of young people at incipient risk of psychosis. Schizophr Bull 22 (2): 283–303.
  4. Broome MR, Woolley JB, Johns LC, et al. (August 2005). Outreach and support in south London (OASIS): implementation of a clinical service for prodromal psychosis and the at risk mental state. Eur. Psychiatry 20 (5-6): 372–8.
  5. PRIME
  6. (COPE)
  7. Emory University
  8. Yung AR, Phillips LJ, Yuen HP, et al. (March 2003). Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group. Schizophr. Res. 60 (1): 21–32.
  9. McGorry PD, Yung AR, Phillips LJ, et al. (October 2002). Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch. Gen. Psychiatry 59 (10): 921–8.
  10. Morrison AP, French P, Parker S, et al. (May 2007). Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk. Schizophr Bull 33 (3): 682–7.
  11. Schäfer Amminger, Papageorgiou Harrigan, Cotton McGorry, Berger (2008). Indicated Prevention of Psychotic Disorders with Long-Chainomega-3 Fatty Acids: A Randomized, Placebo-Controlled Trial. Schizophrenia Research 102.
  12. Yung AR, Yuen HP, McGorry PD, et al. (2005). Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States. Aust N Z J Psychiatry 39 (11-12): 964–71.